Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Johnson and Johnson
Fish and Richardson
Mallinckrodt
Farmers Insurance
US Army
Cerilliant
Deloitte
Baxter
Chubb

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,066,339

« Back to Dashboard

Which drugs does patent 6,066,339 protect, and when does it expire?

Patent 6,066,339 protects AVINZA and is included in one NDA.

This patent has twelve patent family members in twelve countries.
Summary for Patent: 6,066,339
Title: Oral morphine multiparticulate formulation
Abstract:An oral morphine multiparticulate formulation for once-daily administration to a patient, comprising sustained release particles each having a core containing water soluble morphine and an osmotic agent, the core being coated with a rate-controlling polymer coat comprised of ammonio methacrylate copolymers in an amount sufficient to achieve therapeutically effective plasma levels of morphine over at least 24 hours in the patient.
Inventor(s): Stark; Paul (Althone, IE), Cunningham; Sean (Althone, IE), Moodley; Jagathesan (Althone, IE)
Assignee: Elan Corporation, plc (Dublin, IE)
Application Number:08/977,965
Patent Claim Types:
see list of patent claims
Formulation;

Drugs Protected by US Patent 6,066,339

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-001 Mar 20, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-005 Dec 18, 2008 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-002 Mar 20, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-006 Dec 18, 2008 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-003 Mar 20, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-004 Mar 20, 2002 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,066,339

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 239454 ➤ Subscribe
Australia 5408098 ➤ Subscribe
Canada 2306333 ➤ Subscribe
Canada 2558783 ➤ Subscribe
Germany 69721845 ➤ Subscribe
Denmark 1023051 ➤ Subscribe
European Patent Office 1023051 ➤ Subscribe
Spain 2199378 ➤ Subscribe
Japan 2001520187 ➤ Subscribe
Japan 4535613 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Cipla
Deloitte
Mallinckrodt
Harvard Business School
Daiichi Sankyo
UBS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot